Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Giannoudis, Athina ORCID: 0000-0002-7200-1497, Malki, Mohammed Imad, Rudraraju, Bharath, Mohhamed, Hisham, Menon, Suraj, Liloglou, Triantafillos ORCID: 0000-0003-0460-1404, Ali, Simak, Carroll, Jason S and Palmieri, Carlo ORCID: 0000-0001-9496-2718
(2020) Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer. Breast Cancer Research, 22 (1). 126-.


Rogerson, Connor, Sciacovelli, Marco ORCID: 0000-0003-2958-4292, Maddalena, Lucas A, Pouikli, Andromachi, Segarra-Mondejar, Marc, Valcarcel-Jimenez, Lorea, Schmidt, Christina, Yang, Ming, Ivanova, Elena, Kent, Joshua
et al (show 5 more authors) (2023) FOXA2 controls the anti-oxidant response in FH-deficient cells. CELL REPORTS, 42 (7). 112751-.


Hickey, Theresa E, Selth, Luke A, Chia, Kee Ming, Laven-Law, Geraldine, Milioli, Heloisa H, Roden, Daniel, Jindal, Shalini, Hui, Mun, Finlay-Schultz, Jessica, Ebrahimie, Esmaeil
et al (show 14 more authors) (2021) The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer. NATURE MEDICINE, 27 (2). 310-+.


Giannoudis, Athina ORCID: 0000-0002-7200-1497, Malki, Mohammed I, Mohammed, Hisham, Rudraraju, Bharath, Menon, Suraj, Ali, Simak, Carroll, Jason S and Palmieri, Carlo ORCID: 0000-0001-9496-2718
(2020) The regulatory role of activating transcription factor-2 (ATF2) in modulating tamoxifen resistance in estrogen-receptor positive breast cancer. In: San Antonio Breast Cancer Symposium, San Antonio, USA.

This list was generated on Tue Jan 23 21:46:10 2024 GMT.